HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Next-Gen Heart Failure Management Platform Combines Advanced Interatrial Shunting and Hemodynamic Monitoring

By HospiMedica International staff writers
Posted on 12 Jul 2023
Print article
Image: The innovative platform is designed for more personalized, tailored management of heart failure patients (Photo courtesy of Freepik)
Image: The innovative platform is designed for more personalized, tailored management of heart failure patients (Photo courtesy of Freepik)

Heart failure, a progressive condition, affects almost 26 million patients around the world. Patients usually complain of impaired functional independence, poor quality of life, and frequent hospitalization associated with heart failure. Now, a next-generation heart failure management platform aims to deliver advanced interatrial shunting and hemodynamic monitoring to overcome the shortcomings of first-generation devices.

Adona Medical’s (Los Gatos, CA, USA) heart failure management platform comprises an adjustable interatrial shunt with integrated bi-atrial pressure monitoring. The shunt flow channel has an adaptable geometry, allowing it to be enlarged or reduced in size at any time post-implantation. This allows for optimizing the shunting flow or dose based on the patient’s needs during the initial procedure, as well as adjustments to be made in the future with the patient’s evolving condition over time. Additionally, the integrated sensors are capable of automatically capturing pressure readings from both the left and right atria several times a day without the need for patient interaction. These daily readings provide physicians with a detailed understanding of the patient’s hemodynamic status and can improve shunt therapy through informed pharmaceutical management.

“Adona Medical is committed to providing heart failure patients and physicians with technologies that address the shortcomings of currently available solutions. You’d struggle to find a physician comfortable with deciding on a fixed dose of medication for a patient and never being able to alter it in the future or monitor its effects, but this is comparable to the use case for interatrial shunts currently under clinical investigation,” said Brian Fahey, Co-Founder and Chief Executive Officer of Adona Medical. “At Adona, we believe that patient care can be pushed forward by a customizable and adjustable shunting approach combined with an advanced hemodynamic monitoring solution.

Related Links:
Adona Medical 

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Aortic Valve Replacement System
INTUITY Elite
New
Imaging Table
CFPM200

Print article

Channels

Surgical Techniques

view channel
Image: The Elana Heart Bypass System is designed to make suturing obsolete (Photo courtesy of AMT Medical)

Pioneering Sutureless Coronary Bypass Technology to Eliminate Open-Chest Procedures

In patients with coronary artery disease, certain blood vessels may be narrowed or blocked, requiring a stent or a bypass (also known as diversion) to restore blood flow to the heart. Bypass surgeries... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more